![Bitcoin price today: edges down to $96.4k but remains range-bound](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEI5D0I2_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 100.000 | 100.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.048 | 19.779 |
Price to Book | 3.009 | 4.043 |
Price to Sales | 3.669 | 2.422 |
Price to Cash Flow | 11.368 | 16.160 |
Dividend Yield | 1.220 | 1.381 |
5 Years Earnings Growth | 8.481 | 12.141 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.700 | 94.881 |
Technology | 1.300 | 2.640 |
Number of long holdings: 36
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CSL | AU000000CSL8 | 7.58 | 258.30 | +0.54% | |
Hoya Cor | JP3837800006 | 6.93 | 19,210.0 | -0.29% | |
Daiichi Sankyo | JP3475350009 | 6.29 | 3,637.0 | -0.25% | |
Takeda Pharmaceutical | JP3463000004 | 5.85 | 4,210.0 | +1.42% | |
Chugai Pharmaceutical | JP3519400000 | 5.71 | 7,387.0 | +1.88% | |
Otsuka Holdings Ltd | JP3188220002 | 5.26 | 7,600.0 | +3.75% | |
Olympus Corp. | JP3201200007 | 4.84 | 2,054.0 | -9.71% | |
Terumo Corp. | JP3546800008 | 4.82 | 2,811.5 | +0.57% | |
Akeso Inc Ordinary Shares | - | 4.28 | - | - | |
Samsung Biologics | KR7207940008 | 3.54 | 1,185,000 | +0.42% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B USD | 1.68B | 9.12 | 4.33 | 9.96 | ||
Adamant Medtech I USD | 1.68B | 9.18 | 5.06 | 10.75 | ||
EDM Intl S American Growth A USD | 319.6M | 16.42 | -2.50 | 11.74 | ||
LU1811047247 | 305.95M | 4.69 | -10.13 | - | ||
LU1811047593 | 305.95M | 3.96 | -10.76 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review